Date of Publication: 29 May 2025 - Roots Analysis has published its latest report titled ‘‘Antiviral Drugs Market “, offering an in-depth overview of the global landscape. This study provides a historical perspective and a future outlook for the market, analyzing trends and growth patterns from 2025 to 2035. The report explores how the market size has evolved and identifies the major forces shaping its direction in the coming years.
The global antiviral drugs market size is estimated to grow from USD 65 billion in 2024 to reach USD 69 billion in 2025 and USD 127 billion by 2035, representing a higher CAGR of 6.2% during the forecast period. This projected growth is supported by steady expansion across multiple regions and consistent adoption across key crop types. The report refrains from speculative assumptions, offering fact-based analysis of market shifts and potential opportunities.
The research includes a clear breakdown of business activities, competitive strategies, and investment initiatives. It outlines the position of top companies in ‘Antiviral Drugs and discusses their strategic moves in the global space. Their financial performance, product ranges, and operational footprints are presented to support understanding of the competitive structure within the ‘Antiviral Drugs Market.
By Mechanism ofAction
Fusion Inhibitors
DNA Polymerases
Protease Inhibitors
Reverse Transcriptase
Others
By Target Indication
Human Immunodeficiency Virus Infection
Coronavirus Infection
Hepatitis
Herpes Simplex Virus Infection
Cytomegalovirus Infection
Influenza
Others
By Drug Target
Virus Targets
Host Targets
By Type of Therapy
Monotherapy
Combination Therapy
Key GeographicalRegions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Key Companies Profiled
AbbVie
AstraZeneca
Bristol-Myers Squibb
Genentech
Gilead Sciences
GlaxoSmithKline (GSK)
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
ViiV Healthcare
Browse for more related reports
https://vi.anotepad.com/note/read/aawikw9h
https://github.com/koreylanson/skills-github-pagess/issues/9
https://md.picasoft.net/s/qegSMUkSc
https://rv4tbvnoxdt.typeform.com/to/LnQpmcQP
https://gitflic.ru/project/chrisgayle22/roots2/issue/3
https://secure.smore.com/n/jwer7-ai-in-drug-discovery-market
https://tree.taiga.io/project/chrisgayle22-roots/issue/3
https://git.octree.ch/decidim/vocacity/decidim-modules/decidim-module-spam_signal/-/issues/71
https://git.parscoders.com/chris0010/roots/-/issues/4
https://tildegit.org/chris666669/Roots/issues/5
https://docs.aix.inrae.fr/s/uqu4NzVUy
The geographical scope of the study covers AbbVie , AstraZeneca , Bristol-Myers Squibb , Genentech, Gilead Sciences, GlaxoSmithKline (GSK), Johnson & Johnson, Merck, Novartis , Pfizer, Roche , ViiV Healthcare. Each region is examined with respect to current demand, accessibility of products, and regional developments. These geographic insights contribute to a deeper understanding of the global ‘Antiviral Drugs Market share and help identify performance differences between developed and emerging markets.
The report features profiles of key players operating in the ‘Antiviral Drugs sector, including AbbVie , AstraZeneca , Bristol-Myers Squibb , Genentech, Gilead Sciences, GlaxoSmithKline (GSK), Johnson & Johnson, Merck, Novartis , Pfizer, Roche , ViiV Healthcare. These company profiles provide a snapshot of their business strategy, market presence, and major contributions to the ‘Antiviral Drugs Market.
The study further discusses market performance across various regions, product categories, and other segments. It presents a factual evaluation of the ‘Antiviral Drugs industry share and reviews the regulatory and operational dynamics influencing global adoption. The report emphasizes consistency and clarity in presenting the forecast model and expected market trajectory.
Readers are also presented with analysis on corporate strategies including mergers and acquisitions, regional partnerships, and joint ventures. These strategies are reviewed in the context of historical data and current execution trends, offering an informed overview of ‘Antiviral Drugs Market growth potential.
The report highlights the impact of external conditions such as pricing changes, investment flow, and emerging business models. It avoids speculation and focuses on available insights that can guide real-world business decisions. Coverage includes major areas of interest for companies exploring new opportunities in the market for ‘Antiviral Drugs.
Research Methodology
This study is backed by structured primary and secondary research methodologies. Roots Analysis used a range of reliable sources including company disclosures, government records, and expert interviews. The research framework supports accurate and transparent analysis, allowing businesses to derive actionable insights from the ‘Antiviral Drugs Market forecast.
For more information or to request a personalized version of this report, please contact our team at sales@rootsanalysis.com. We are happy to support your specific business objectives with customized research solutions.
About Roots Analysis
Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. The leading market research company – Roots Analysis has different product offerings. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.
Contact Details
Roots Analysis
Gaurav Chaudhary
+1 (857) 387 7999
+44 (748) 188 1310
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek